Feed Top Reports Pricing

⌘K

16:16:28·21d

SECFilingvia Quantisnow

SEC Form DEFA14A filed by EVgo Inc.

ByQuantisnow·Wall Street's wire, on your screen.

EVGO· EVgo Inc.

Technology

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVGO (EVgo Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

EVGO
EVgo Inc.
Technology

Recent analyst ratings

Mar 25UpdateAnalyst-
Oct 10UpdateUBS$8.50
Oct 3UpdateTD Cowen$7.00
Oct 3UpdateJP Morgan$7.00
Jul 22UpdateUBS$4.00
Jun 5UpdateThe Benchmark Company$3.00

Related

INSIDER21d
SEC Form 4 filed by Motlagh Katherine
SEC21d
SEC Form DEF 14A filed by EVgo Inc.
SEC29d
Amendment: SEC Form SCHEDULE 13G/A filed by EVgo Inc.
ANALYST31d
EVgo Inc. downgraded by Analyst
INSIDER38d
Chief Executive Officer Khan Badar converted options into 222,222 shares and covered exercise/tax liability with 56,334 shares, increasing direct ownership by 18% to 1,037,603 units (SEC Form 4)
INSIDER38d
President Kish Dennis G converted options into 157,407 shares and covered exercise/tax liability with 80,089 shares, increasing direct ownership by 45% to 248,315 units (SEC Form 4)
INSIDER38d
Officer Sullivan Francine converted options into 74,074 shares and covered exercise/tax liability with 29,149 shares, increasing direct ownership by 16% to 329,012 units (SEC Form 4)
SEC49d
SEC Form 10-K filed by EVgo Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022